Innoscience at a Strategic Crossroad

Innoscience faces significant losses despite growing sales as it scales 8-inch GaN capacity. Its viability hinges on boosting international revenue and fab utilization.

Innoscience recent attention has focused on IP disputes and new partnerships, yet the company’s financial health remains the more critical challenge. Despite growing overseas sales and improving operations, Innoscience continues to face significant losses as it rapidly scales its 8-inch GaN capacity. The company’s long-term viability now depends on accelerating international revenue and achieving higher fab utilization. As GaN demand rises across datacenters, automotive, consumer and emerging robotics applications, reliable and geopolitically resilient wafer supply becomes essential.